FDA Focuses On Harmonization With The Launch Of Generic Drug Cluster

The US Food and Drug Administration has announced the launch of the Generic Drug Cluster, “the first forum established to address generic drug development and increase scientific alignment among the world’s leading regulatory agencies.” The Generic Drug Cluster has been launched through the Global Generic Drug Affairs team established by the FDA’s Office of Generic Drugs. 

“Our opportunity for harmonization is now and movement toward common standards for global development for generics can improve access to generic products with substantial health care savings,” said Sarah Ibrahim,...